NLRP3 and CINCA syndrome: A Y861C mutation in NLRP3 has been reported in patients with chronic infantile neurologic cutaneous and articular syndrome (CINCA), and the Y861F mutation in NLRP3 has been shown to enhance NLRP3 inflammasome activation compared to wild-type NLRP3 (80).